Clinical Trial Update: Implementing ctDNA and Circular DNA in Patients With Localized Pancreatic Cancer [NA]

View source ↗

Summary

This entry reports a recruiting clinical trial investigating circulating tumor DNA (ctDNA) and circular DNA in patients with resectable pancreatic cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Ductal Adenocarcinoma

Snippet

Sponsor: Copenhagen University Hospital at Herlev | Conditions: Resectable Pancreatic Cancer | NA | Status: RECRUITING